HCIA Inc., the Baltimore health data company, said yesterday that it has formed a relationship with Bristol-Myers Squibb Co. to develop uses for U.S. health care data collected for the pharmaceutical giant.
"Working with Bristol-Myers Squibb expands use of HCIA's clinical databases and analytical tools within the pharmaceutical industry," George Pillari, HCIA chairman and chief executive, said in a statement.
The multiyear deal is "built around HCIA's core expertise in clinical data handling and database management," Pillari said.
HCIA collects databases on hospital costs and other health costs and outcomes and sells the information to hospitals, insurers and drug companies to assist in managing the medical costs of populations.
HCIA and Bristol-Myers Squibb will focus on several major projects, including health information integration, outcomes research, health economics, quality management and accreditation.
Both organizations will develop tools and programs that focus on appropriate clinical and cost-effective use of pharmaceuticals, the companies said.
Pub Date: 12/09/98